Quick charity verification for Philadelphia Endocrine Society (EIN: 200106268)
Verdict: Philadelphia Endocrine Society appears trustworthy
92/100Mission Score
$238KRevenue
$654KAssets
0Red Flags
5Strengths
No red flags identified.
Strengths
Strong program spending ratio (90% in 2023)
Consistent asset growth over the past decade (from $127,902 in 2014 to $586,276 in 2023)
Zero reported officer compensation, indicating volunteer leadership
No reported liabilities across all filings, showing strong financial stability
Excellent transparency with 13 years of consistent IRS 990 filings
Spending Breakdown
How Philadelphia Endocrine Society allocates its funds across programs, administration, and fundraising.
90%
Program Spending
Healthy — majority goes to mission
7%
Admin Costs
Reasonable — admin costs in check
3%
Fundraising
Within typical range
How to read this: Well-run charities typically spend 75% or more on programs, keep admin under 25%, and fundraising under 15%. A high program ratio means more of every dollar goes directly to the mission.
How to Interpret This Report
What Red Flags Mean
Red flags are potential warning signs identified by AI analysis of IRS 990 filings. They may indicate issues like declining revenue, high executive pay relative to program spending, lack of transparency, or governance concerns. A single red flag does not necessarily mean an organization is untrustworthy, but multiple flags warrant further investigation before donating.
What Mission Score Measures
The Mission Score (0-100) evaluates how effectively a nonprofit fulfills its stated purpose. It combines multiple factors: program spending efficiency (how much goes to programs vs. overhead), financial health and sustainability, governance quality, transparency in reporting, and consistency of operations over time. A score of 70+ indicates strong alignment with the organization’s mission.
Using This Data for Donation Decisions
Use this report as one input in your decision. Look at the overall Mission Score for a quick assessment, review red flags and strengths for specific concerns, check the spending breakdown to see where money goes, and compare executive compensation to the organization’s size. Consider viewing the full transparency report for deeper analysis, and always verify tax-exempt status with the IRS before making large donations.
Frequently Asked Questions about Philadelphia Endocrine Society
Is Philadelphia Endocrine Society a legitimate charity?
Based on AI analysis of IRS 990 filings, Philadelphia Endocrine Society (EIN: 200106268) appears trustworthy. Mission Score: 92/100. 0 red flags identified, 5 strengths noted.
Is Philadelphia Endocrine Society a good charity to donate to?
Philadelphia Endocrine Society has a Mission Score of 92/100. Revenue: $238K. Assets: $654K. Review the full transparency report for detailed spending breakdown and executive compensation analysis.
What is the EIN for Philadelphia Endocrine Society?
The Employer Identification Number (EIN) for Philadelphia Endocrine Society is 200106268. This is the unique tax ID assigned by the IRS.
What is a Mission Score?
The Mission Score is a 0-100 rating that measures how effectively a nonprofit fulfills its stated mission. It factors in program spending efficiency, financial transparency, governance practices, and outcome reporting. Scores above 70 indicate strong mission alignment, 40-69 suggest mixed performance, and below 40 signals potential concerns.
How does Philadelphia Endocrine Society spend its money?
Philadelphia Endocrine Society allocates 90% to programs, 7% to administration, and 3% to fundraising. Healthy nonprofits typically spend 75%+ on programs.
How can I verify Philadelphia Endocrine Society's tax-exempt status?
You can verify Philadelphia Endocrine Society's tax-exempt status using EIN 200106268 on the IRS Tax Exempt Organization Search (TEOS) at apps.irs.gov/app/eos. You can also request copies of their Form 990 directly from the organization, as they are required by law to provide them upon request.
AI Transparency Report
The Philadelphia Endocrine Society demonstrates sound financial health with consistent asset growth and a strong program focus. Over the past decade, assets have grown from $127,902 in 2014 to $586,276 in 2023, indicating effective financial management and accumulation of resources. The organization consistently spends a high percentage of its expenses on program services, as evidenced by the 2023 filing where 90% of expenses were allocated to programs, with only 10% for administrative and fundraising costs. This efficiency suggests that the vast majority of funds directly support its mission.
The society's transparency is excellent, with 13 years of consistent IRS 990 filings available. The absence of reported liabilities across all filings further underscores a healthy financial position and responsible fiscal practices. The consistent reporting of 0% officer compensation also highlights a volunteer-driven leadership model, which can be a positive indicator of dedication to the mission and efficient use of funds.